Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TY-0201 (bisoprolol transdermal patch) in chronic heart failure
jRCT2080222593Phase 2
- Sponsor
- TOA EIYO
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bisoprolol in chronic heart failure (CHF), coronary arteriosclerosis, dilated cardiomyopathy (DCM) and 1 more, sponsored by TOA EIYO.
02
Drugs
bisoprolol
03
Conditions
chronic heart failure (CHF)coronary arteriosclerosisdilated cardiomyopathy (DCM)hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on jRCT2080222593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222593.